Lidocaine and Steroids for Headache in Subarachnoid Hemorrhage
This study is looking at whether infusing lidocaine, with or without dexamethasone (a steroid), into a specific artery in the head can help reduce severe headaches in people who have had a subarachnoid hemorrhage (SAH). SAH is bleeding in the space around the brain. Researchers want to see if this treatment is safe and if it lowers pain levels and the need for opioid pain medications. You may be able to join if you are 18 to 100 years old, have been diagnosed with aneurysmal SAH (a type of SAH) with specific grades (Hunt and Hess Grades 1-2), and do not have allergies to the study medications or certain other brain conditions. The study plans to enroll 15 participants. Success will be measured by changes in your pain scores and how much pain medication you need.
- Study design
- This is a single-arm study, meaning all participants will receive an intervention, with a planned enrollment of 15 people. It compares three groups: lidocaine alone, lidocaine with dexamethasone, and no injection.
- What's involved
- You will undergo a standard brain angiogram (an imaging test) and may receive the medication during this procedure. You will be monitored closely for changes in pain and medication use.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will have follow-up visits at 1, 3, and 6 months after the procedure to track outcomes and side effects.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kan Peter, MD · PRINCIPAL_INVESTIGATOR · University of Texas Medical Branch, Galveston
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Visual Analog Scale (VAS) ScoreBaseline
The Visual Analog Scale (VAS) is a validated, subjective measure for assessing pain intensity. It consists of a 10-centimeter horizontal line anchored by two extremes: "no pain" (0 mm) and "worst imaginable pain" (100 mm). Participants indicate their pain level by marking a point along the line that corresponds to their current pain intensity. The score is determined by measuring the distance in millimeters from the "no pain" anchor to the participant's mark, yielding a score between 0 and 100 mm. Higher scores represent greater pain intensity.
- Visual Analog Scale (VAS) ScoreEvery 4 hours for 24 hours following the procedure
The Visual Analog Scale (VAS) is a validated, subjective measure for assessing pain intensity. It consists of a 10-centimeter horizontal line anchored by two extremes: "no pain" (0 mm) and "worst imaginable pain" (100 mm). Participants indicate their pain level by marking a point along the line that corresponds to their current pain intensity. The score is determined by measuring the distance in millimeters from the "no pain" anchor to the participant's mark, yielding a score between 0 and 100 mm. Higher scores represent greater pain intensity.